Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study
Adam M. Brickman(Columbia University), Richard Mayeux(Columbia University), Patrick J. Lao(Columbia University Irving Medical Center), Yaakov Stern(Columbia University), Jeffrey L. Dage(Indiana University School of Medicine), Danurys Sanchez(Columbia University Irving Medical Center), Jennifer J. Manly(Alzheimer’s Disease Neuroimaging Initiative), Andrew F. Teich(Columbia University), Dolly Reyes‐Dumeyer(Columbia University), Rafael Lantigua, David Airey(University of Surrey), Nicholas K. Proctor(Eli Lilly (United States)), Jean Paul Vonsattel(Harvard University), Lawrence S. Honig(Columbia University)
Cited by 388
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k